Characteristics of inflammatory markers in patients with acute heart failure
DOI:
https://doi.org/10.56294/hl2023269Keywords:
heart failure, hematological markers, InflammationAbstract
Introduction: The available scientific evidence3-4 allows us to state that the development and progression of heart failure are underlain by immunological and inflammatory mechanisms that are associated with oxidative stress.
Objective: To determine the characteristics of hematological markers of inflammation in hospitalized patients with HF on admission.
Material and methods: A descriptive-cross-sectional study of 100 patients who were admitted to the Cardiology ward with a diagnosis of HF from 2018 to 2020 was carried out. For data collection, the survey that was filled out during the review of medical records was used. clinics once the patient is discharged. For the processing, a database was created with the SPSS system. The principles of the Declaration of Helsinki were respected.
Results: It was shown that the greatest left atrial dilation is significantly correlated with the elevation of the elevated neutrophils / lymphocytes (NRL) (80%), while only 20% of these patients present the NLR up to 2.9. There is a significant association between the RNL up to 2.9 and the state at discharge alive, represented by 63%, as well as the elevated platelet/lymphocyte ratio (≥ 116) with the deceased discharge (100%), while the live discharged with this same condition were only 22.8%.
Conclusions: The hematological markers of inflammation and oxidative stress, Neutrophils/lymphocytes and platelets/lymphocytes ratio, are characterized by their significant association with mortality in patients hospitalized for heart failure.
References
1. Wang XY, Zhang F, Zhang C, Zheng LR, Yang J. The Biomarkers for Acute Myocardial Infarction and Heart Failure. BioMed Research International. 2020 [cited 2021 marzo 02] (5):1-14.Disponible en https://doi.org/10.1155/2020/2018035
2. De Abreu, Vensentini, Mariani J, Gagliardi J, Doval H, Tajer C. Síndromes coronarios agudos en instituciones públicas y no públicas de Argentina. MEDICINA (Buenos Aires) 2019; 79: 461-467
3. Ruparelia N, Choudry R. Inflammation and atherosclerosis; What is on The Horizons? Heart 2020 Jan;106(1):80-85 doi: 10.1136/heartjnl-2018-314230.
4. Rayes J, Bourne JH, Brill A, Watson SP. The dual role of platelet-innate immune cell interactions in thrombo-inflammation. Res Pract Thromb Haemost. 2019 Oct 17;4(1):23-35. doi: 10.1002/rth2.12266. eCollection 2020 Jan.
5. Miranda Quintana OM, Gómez NE, Venegas Lobato M, Ferrer Martín Y. Sistema de vigilancia del síndrome de respuesta inflamatoria sistémica. Una herramienta para la prevención. Mediciego. 2014 [citado 12 jun 2022];20(1).Disponible en: https://revmediciego.sld.cu/index.php/mediciego/article/view/137
6. Swirski FK, Nahrendorf M. Cardioimmunology: the immune system in cardiac homeostasis and disease. Nature Reviews Immunology 2018;(18):733–744.
7. Murphy SP, Kakkar R, McCarthy CP, Januzzi JL. Inflammation in Heart Failure. Journal of the American College of Cardiology. Volume 75, Issue 11, March 2020 DOI: 10.1016/j.jacc.2020.01.014
8. Ridker P, Libby P, MacFadyen JD, Thuren T, Ballantyne T Ch, Fonseca F, Koenig W et al. on behalf of the CANTOS Trial Group. Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). European Heart Journal (2018) 39, 3499–3507
9. Konradi J, Mollenhauer M, Baldus S, Klinke A. Redox–Sensitive mechanisms underlyng vascular disfunction in heart failure. Free radical Research 2015;49(6)721-42
10. Meier S, Henkens M, Heyman S. Louise RB. Unlocking the value of white blood cells for heart failure diagnosis. J Cardiovascular translational Research 2021;4:53-62
11. Lucas Perez-Romero FJ, Panisello Royo JM, Simón Garcia MA, Villar Inarejose J, Madrona Marcos F, Sadek IM, Octavio Sánchez R, Peiró Monzof F. Análisis comparativo del manejo de la insuficiencia cardiaca en 2 medios diferentes: rural versus urbano. (Estudio ALBAPIC).
12. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Rev Esp Cardiol. 2016;69(12): 1167.e1-e85
13. Acosta MF, Monastyrski AV, Sarmiento P. Correlación entre criterios electrocardiográficos de crecimiento auricular izquierdo y hallazgos ecocardiográficos. Revista CONAREC 2019;34(150):160-164.
14. Delcea C, Adrian BC, Andrei DG. The neutrophil to lymphocyte ratio in heart failure: a comprehensive review. ROM. J. INTERN. MED., 2019, 57, 4, 296–314. 10.2478/rjim-2019-0018
15. Turcato G, Sanchis GF, Cervellin G, Zorzi E, Sivero V, Salvagno GL, Tenci A, Lippi G. Evaluation of neutrophil-lymphocyte and platelet-lymphocyte ratios as predictors of 30-day mortality in patients hospitalized for an episode of acute decompensated heart failure. J Med Biochem 2019; 38(4): 452–460, DOI: 10.2478/jomb-2018-0044
Published
Issue
Section
License
Copyright (c) 2023 Lucia Nivia Turro Mesa, Germán Del Río Caballero, Germán Del Río Caballero, Rita María Mesa Valiente, Germán Del Río Mesa, Margarita Montes de Oca (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
